Knockdown of CCT2 was found to decrease the metastasis rate of breast cancer cells by inhibiting the activity and expression of MMP2/9, which act as matrix metalloproteases to degrade the extracellular matrix.83 Here, CCT2 is linked to breast carcinoma.